Provita, a company operated by science- and business-oriented high school students, is developing a "flying syringe" approach to managing mosquito-born diseases. The company hopes to develop mosquitoes that can produce a West Nile virus vaccine. The company also is working on a product called Coagula intended to reduce the need for injections to treat von Willebrand disease and hemophilia.

Full Story:

Related Summaries